{"tid":2495457,"cid":5,"subCid":10,"title":"黨政府：警告市民勿自行溝針 以免影響國家溝針大計","createTime":"2021-04-19T07:52:34.000Z","updateTime":"2021-04-19T07:53:51.000Z","uid":21470,"like":0,"dislike":1,"uniUserReply":2,"replies":[{"pid":"9348818aba26eb60d058c89197b12b6ef46bdfab","tid":2495457,"uid":21470,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2021-04-19T07:52:34.000Z","msg":"孔繁毅︰絕不建議市民自行溝針<br />\n<br />\n一名32歲男子自行「溝針」 ，先後2劑復必泰和1劑科興疫苗。港大內科學系臨床教授孔繁毅表示，據衞生署資料，這名男子情況穩定，專家稍後會在門診了解他的情況，相信如果在短期內例如未來數星期，這名男子都沒有不良反應，應代表沒有大問題。<br />\n<br />\n孔繁毅表示，據他所知世界上沒有類似的「溝針」個案，這種做法理論上對接種者應該沒有不良影響，但仍要觀察一段時間才可下這定論。他說絕對不建議市民自行「溝針」，指接種兩劑復興或兩劑復必泰疫苗已有足夠保護。<br />\n<br />\n孔繁毅說，港大有關「溝針」的臨床研究已展開，暫時有10多人參與，已接種第一劑復必泰疫苗，希望數月內完成，了解抗體產生表現。他說，參與研究下的「溝針」與自行「溝針」不同，研究是按既定程序與時間進行，期間會密切監察接種者有無不良反應以及抗體產生表現，而且只會打兩針。<br />\n<br />\n<a href=\"https://news.rthk.hk/rthk/ch/component/k2/1586547-20210419.htm?spTabChangeable=0\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fnews.rthk.hk%2Frthk%2Fch%2Fcomponent%2Fk2%2F1586547-20210419.htm%3FspTabChangeable%3D0&d=CDYmK9DOGPUFxvwNhHfqx9w%2Be0OQbTcODApWAJdetE8%3D&h=a4723ee9\" data-ef-url=\"https://embed.lih.kg/frame?u=https%3A%2F%2Fnews.rthk.hk%2Frthk%2Fch%2Fcomponent%2Fk2%2F1586547-20210419.htm%3FspTabChangeable%3D0&h=88d1a66d\" data-auto-link target=\"_blank\">https://news.rthk.hk/rthk/ch/component/k2/1586547-20210419.htm?spTabChangeable=0</a>"},{"pid":"3898366a01de77b8cb6f0457a82c6bc206c80b19","tid":2495457,"uid":242537,"like":1,"dislike":0,"score":1,"citedBy":0,"replyTime":"2021-04-19T07:53:51.000Z","msg":"新marvel：港豬溝針俠<img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" />"}]}